Comparison of HFNC and COT to Diaphragm Function of Post-upper Abdominal Surgery Patients

December 30, 2019 updated by: Sidharta K. Manggala, Indonesia University

Comparison of High-Flow Nasal Cannula (HFNC) and Conventional Oxygen Therapy (COT) to Diaphragm Function of Post-Upper Abdominal Surgery Patients

This study aims to compare diaphragm thickness, air lung distribution, and several clinical and laboratory parameters on post abdominal surgery patients with conventional oxygen therapy vs high-flow nasal cannula

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

"Approval from Ethical Committee of Faculty of Medicine Universitas Indonesia was acquired prior conducting the study. Subjects were recruited using consecutive sampling method. Subjects underwent upper-abdominal surgery were screened. Eligible and consented subjects were randomized into intervention group (high-flow nasal cannula) and control group (conventional oxygen therapy). Subject and operation characteristics were recorded prior to intervention.

Clinical parameters (vital signs, Borg Score, ICON) were recorded in 10 specific times. diaphragm thickness data using abdominal ultrasonography (USG) and air lung distribution data using Electrical Impedance Tomography were collected in 7 specific times while lactate and blood gas analysis were done 4 times. "

Study Type

Interventional

Enrollment (Actual)

66

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • DKI
      • Jakarta Pusat, DKI, Indonesia
        • Cipto Mangunkusumo Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients from 18 - 65 yrs old,
  • American Society of Anaesthesia (ASA) status I-III,
  • BMI < 30, patent airway,
  • Measurement of Exercise Tolerance before Surgery (METS) Score > 4,
  • P-POSSUM score <10%,
  • agreed to the study

Exclusion Criteria:

  • uncooperative subjects,
  • DNR (do not resuscitate) patients,
  • patients with tracheostomy, pleural effusion, pneumothorax or pulmonary atelectasis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: "High flow nasal cannula (HFNC)"
"HFNC group: those who receive high-flow nasal cannula therapy
"HFNC: high-flow nasal cannula therapy COT: conventional oxygen therapy"
EXPERIMENTAL: conventional oxygen therapy (COT)
COT group: those who receive conventional oxygen therapy group
"HFNC: high-flow nasal cannula therapy COT: conventional oxygen therapy"

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
diaphragm thickness
Time Frame: 2 months
diaphragm thickness are measured sequentially by abdominal ultrasonography (mm)
2 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
electrical impedance tomography (EIT) data
Time Frame: 2 months
measured data to assess lung ventilation volume and air distribution
2 months
partial 02 pressure
Time Frame: 2 months
partial 02 pressure were collected from arterial blood gas analysis (mmHg)
2 months
partial carbondioxyde pressure
Time Frame: 2 months
partial CO2 pressure were collected from arterial blood gas analysis (mmHg)
2 months
ICON
Time Frame: 2 months
ICON were measured to observe hemodynamic status
2 months
lactate
Time Frame: 2 months
lactate were measured from arterial blood
2 months
heart rate
Time Frame: 2 months
measured from monitor (bpm)
2 months
mean arterial pressure
Time Frame: 2 months
measured from monitor (mmHg)
2 months
respiratory rate
Time Frame: 2 months
bpm
2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 1, 2019

Primary Completion (ACTUAL)

November 1, 2019

Study Completion (ACTUAL)

December 30, 2019

Study Registration Dates

First Submitted

June 27, 2019

First Submitted That Met QC Criteria

August 15, 2019

First Posted (ACTUAL)

August 16, 2019

Study Record Updates

Last Update Posted (ACTUAL)

January 2, 2020

Last Update Submitted That Met QC Criteria

December 30, 2019

Last Verified

December 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • IndonesiaUAnes028

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post Abdominal Surgery

Clinical Trials on HFNC; COT

3
Subscribe